MX9701080A - Derivados dtpa dimericos y sus complejos de metal agentes farmaceuticos que contienen estos complejos, su uso en el diagnistico y terapia asi como tambien el proceso para la produccion de complejos y agentes. - Google Patents

Derivados dtpa dimericos y sus complejos de metal agentes farmaceuticos que contienen estos complejos, su uso en el diagnistico y terapia asi como tambien el proceso para la produccion de complejos y agentes.

Info

Publication number
MX9701080A
MX9701080A MX9701080A MX9701080A MX9701080A MX 9701080 A MX9701080 A MX 9701080A MX 9701080 A MX9701080 A MX 9701080A MX 9701080 A MX9701080 A MX 9701080A MX 9701080 A MX9701080 A MX 9701080A
Authority
MX
Mexico
Prior art keywords
pharmaceuticals
complexes
diagnosis
preparing
same
Prior art date
Application number
MX9701080A
Other languages
English (en)
Inventor
Werner Krause
Franz-Karl Maier
Michael Bauer
Wolf-Ruediger Press
Gabriele Schuhmann-Giampieri
Johannes Platzek
Heribert Schmitt-Willich
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MX9701080A publication Critical patent/MX9701080A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A61K51/048—DTPA (diethylenetriamine tetraacetic acid)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Abstract

Nuevos derivados de dímeros DTPA que tiene la formula general (I) que consisten de los incrementos (A) y (B) que están interconectados por uno de un par de substituyentes R1 y R1', R2 y R2', R15 y R15', R1 y R2', R1' y R2, R1' y R15, R1 y R15', R2 y R15', R2' y R15. Los pares de substituyentes de interconexion se establecen para un residuo de heterociclo, un residuo de fenileno, una cadena de alquileno C0-C30 o una cadena de aralquileno C7-C30, que pueden estar opcionalmente substituidos por 1-4 hidroxi, alcoxi con uno o 6 átomos de carbono, grupos carboxi o mercapto y/o interrumpidos por 1 a 6 átomos de oxígeno, nitrogeno o azufre o grupos sulfinilo y/o sulfonilo; Y representa un átomo de hidrogeno y/o un equivalente o ion metálico de un elemento que tiene numeros atomicos 21-32, 37-39, 42-51 y 57-83; y X y X' representan un grupo -OY o -CONR5R6. También se describe el uso de los complejos de metal en diagnostico de resonancia magnética nuclear y/o rayos X, en radio diagnostico y radioterapia, así como un proceso para preparar los mismos.
MX9701080A 1994-08-08 1995-08-08 Derivados dtpa dimericos y sus complejos de metal agentes farmaceuticos que contienen estos complejos, su uso en el diagnistico y terapia asi como tambien el proceso para la produccion de complejos y agentes. MX9701080A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428874A DE4428874A1 (de) 1994-08-08 1994-08-08 Dimere DTPA-Derivate und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
PCT/EP1995/003142 WO1996005167A1 (de) 1994-08-08 1995-08-08 Dimere dtpa-derivate und deren metallkomplexe, diese komplexe enthaltende pharmazeutische mittel, deren verwendung in der diagnostik und therapie sowie verfahren zur herstellung der komplexe und mittel

Publications (1)

Publication Number Publication Date
MX9701080A true MX9701080A (es) 1997-05-31

Family

ID=6525715

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701080A MX9701080A (es) 1994-08-08 1995-08-08 Derivados dtpa dimericos y sus complejos de metal agentes farmaceuticos que contienen estos complejos, su uso en el diagnistico y terapia asi como tambien el proceso para la produccion de complejos y agentes.

Country Status (21)

Country Link
US (1) US5695737A (es)
EP (1) EP0775104B1 (es)
JP (1) JPH10503777A (es)
KR (1) KR970704668A (es)
AT (1) ATE179696T1 (es)
AU (1) AU695878B2 (es)
CA (1) CA2197074A1 (es)
CZ (1) CZ40597A3 (es)
DE (2) DE4428874A1 (es)
DK (1) DK0775104T3 (es)
ES (1) ES2134487T3 (es)
FI (1) FI970535A0 (es)
GR (1) GR3030827T3 (es)
HU (1) HUT77532A (es)
IL (1) IL114858A0 (es)
MX (1) MX9701080A (es)
NO (1) NO970602L (es)
PL (1) PL318503A1 (es)
SK (1) SK17397A3 (es)
WO (1) WO1996005167A1 (es)
ZA (1) ZA956650B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713045B1 (en) 1995-06-02 2004-03-30 Research Corporation Technologies, Inc. Targeted magnetic resonance imaging agents for the detection of physiological processes
US6770261B2 (en) 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
IT1290417B1 (it) * 1996-08-02 1998-12-03 Bracco Spa Composti chelanti derivati di acidi poliamminopolicarbossilici, loro chelati con ioni metallici paramagnetici, loro preparazione ed
DE19646762B4 (de) * 1996-11-04 2004-05-13 Schering Ag Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
CA2309749A1 (en) 1997-11-17 1999-05-27 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
WO2002006287A2 (en) 2000-07-17 2002-01-24 California Institute Of Technology Macrocyclic mri contrast agents
WO2002028441A2 (en) 2000-10-04 2002-04-11 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4915933A (en) * 1986-06-26 1990-04-10 The University Of New Mexico Mixed complexes as shift and contrast reagents in NMR imaging and spectroscopy
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5482700A (en) * 1987-03-31 1996-01-09 Schering Aktiengesellschaft Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
FR2652004B1 (fr) * 1989-09-21 1994-10-28 Immunotech Partners Nouveaux derives hydrophiles, application au diagnostic et a la therapeutique, kits diagnostiques ou therapeutiques et reactifs immunologiques.
US5244816A (en) * 1989-10-11 1993-09-14 Akzo N.V. Method for purifying chelator conjugated compounds
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
ES2116291T3 (es) * 1989-10-23 1998-07-16 Nycomed Salutar Inc Agentes quelantes de metales en sitios multiples.
WO1992005804A1 (en) * 1990-09-27 1992-04-16 Brunswick Corporation Chelating agents
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
US5466439A (en) * 1992-11-12 1995-11-14 Magnetic Research, Inc. Polymeric contrast enhancing agents for magnetic resonance images
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images

Also Published As

Publication number Publication date
FI970535A (fi) 1997-02-07
ZA956650B (en) 1996-03-19
CZ40597A3 (en) 1997-07-16
ATE179696T1 (de) 1999-05-15
KR970704668A (ko) 1997-09-06
AU3343395A (en) 1996-03-07
DE59505856D1 (de) 1999-06-10
DK0775104T3 (da) 2000-01-03
US5695737A (en) 1997-12-09
EP0775104A1 (de) 1997-05-28
GR3030827T3 (en) 1999-11-30
JPH10503777A (ja) 1998-04-07
CA2197074A1 (en) 1996-02-22
SK17397A3 (en) 1997-11-05
IL114858A0 (en) 1995-12-08
NO970602D0 (no) 1997-02-10
EP0775104B1 (de) 1999-05-06
HUT77532A (hu) 1998-05-28
WO1996005167A1 (de) 1996-02-22
DE4428874A1 (de) 1996-02-22
AU695878B2 (en) 1998-08-27
FI970535A0 (fi) 1997-02-07
NO970602L (no) 1997-02-10
PL318503A1 (en) 1997-06-23
ES2134487T3 (es) 1999-10-01

Similar Documents

Publication Publication Date Title
IL111083A0 (en) Tetraazacyclododecane macrocycle derivatives, pharmaceutical compositions and diagnostic compositions containing the same
DK0641767T3 (da) Cytotoksiske stilbenderivater og farmaceutisk præparat indeholdende disse derivater
PL315182A1 (en) Derivatives o substituted morpholine and their application as pharmaceutic agents
MX9701080A (es) Derivados dtpa dimericos y sus complejos de metal agentes farmaceuticos que contienen estos complejos, su uso en el diagnistico y terapia asi como tambien el proceso para la produccion de complejos y agentes.
MX9710353A (es) Benzotriazoles microbicidas.
TW257757B (es)
IL108634A0 (en) Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
PH25859A (en) Composition for treatment of ischemic disorder
NZ236803A (en) Tetra-aza macrocyclic complexing agents for metal ions, optionally attached to another macromolecule; therapeutic and diagnostic uses
DE69029103T2 (de) Tri-aza-Makrocyclen und Verfahren zu ihrer Herstellung
DK0835888T3 (da) En ikke-tværbundet anionbytterharpiks og farmaceutisk sammensætning indeholdende denne
ATE141058T1 (de) Bilderzeugungsmittel für diagnose
AU638018B2 (en) N-substituted lauramides, their preparation and compositions in which they are present
DE69018662D1 (de) Tetraaza-makrocyclische Verbindungen und Verfahren zu deren Herstellung.
EP0639082A4 (en) METHOD AND REAGENTS FOR PRODUCING TECHNETIUM-99M COMPLEXES.
MX9606665A (es) Derivados de acido 3-amino-2-mercaptobenzoico y procesos para su preparacion.
MY105538A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them.
FI935243A (fi) Pyridonkarboxylsyraderivat
DK0455380T3 (da) Tetraaza-makrocykler, fremgangsmåder til fremstilling deraf og deres anvendelse til magnetisk resona ns-visualisering
ES471778A1 (es) Procedimiento para la obtencion de derivados de poliol bis nitrosoureidos
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
DE3060367D1 (en) Derivatives of 2-benzoyl-4-nitro anilides, their preparation and their use as medicines
MY102438A (en) Tetrahydrofuran derivatives, processes for their preparation and their use as fungicides.
NZ315609A (en) 8-N-Anthrazalone derivatives
JPS6450867A (en) Salts of thiamorpholinonecarboxylic acid and 2,4-diaminopyrimidine derivative and use for cosmetic and pharmaceutical composition

Legal Events

Date Code Title Description
FA Abandonment or withdrawal